This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.


This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.


This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

6-9 March 2024
Florence, Italy
On-site and virtual

21-24 June 2024
Orlando, USA
On-site and virtual

30 August - 2 September 2024
London, United Kingdom
On-site and virtual
EASD 2024

10-13 September 2024
Madrid, Spain
On-site and virtual

Over 483 million people are living with type 2 diabetes and 1.2 million are living with type 1 diabetes around the world. These numbers are steadily growing and put a strain on individuals, families, and healthcare systems.

As a healthcare professional, diabetes conferences are ways to get up-to-date about everything diabetes. They also provide great opportunities to network with diabetologists, endocrinologists, and other diabetes professionals. Join international experts, doctors, research scholars, general practitioners, student delegates and exhibitors from all over the world for the latest advances and resources for this disease.

Here on CongressHub, we bring inspiration, videos, highlights, and other content directly to you.

With over a century of diabetes care innovation and experience, Novo Nordisk is committed to driving change to improve treatment options for people living with diabetes. From developing more effective medicines to improving delivery systems, we're building on our heritage to make diabetes management simpler.

As we look to the future, we hope to bring greater flexibility and a more holistic approach to diabetes care. At diabetes conferences, we present our groundbreaking innovations, products, and science. We want to engage with healthcare professionals and provide support for their clinical practice and patients' needs. By sharing knowledge and insights, we hope we can all work together to defeat diabetes.

Defeating diabetes and other serious chronic diseases is not something we at Novo Nordisk can tackle alone. In our research, development, production and commercial operations, we work with partners who complement our own expertise.

We are always on the lookout for new opportunities with people and organizations who are interested in collaborating to change patients’ lives, together.

And so, Novo Nordisk will be at various diabetes conferences in 2023. Just as we have in other years, we are working to help accelerate scientific discovery and innovation in mutual areas of interest.

Digital Health Innovations

As an increasing number of people worldwide are living with diabetes, our device and digital therapeutic innovations have the potential to support diabetes management.1-3
Understanding GLP-1

Learn what GLP-1 is, how it works in the body, and why it is important.
ASCVD in type 2 diabetes

Atherosclerosis is the predominant cause of CVD and death in people with type 2 diabetes.
Time in Range

Time in Range is a new clinical metric within diabetes management that complements HbA1c providing a more complete picture of daily glucose levels.
Diabetes What’s Next

Help your patients navigate life with diabetes.


IDF. Diabetes Atlas, 9th Edition.


Klonoff DC et al. JDiabetes SciTechnol. 2018;12(3):551-553.


Peter Adolfsson et al. Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen. DIABETES TECHNOLOGY & THERAPEUTICS Volume 22, Number 10, 2020.